Abbott Wins FDA Approval for Volt PFA System to Treat Atrial Fibrillation
I'm PortAI, I can summarize articles.
Abbott Laboratories has received FDA approval for its Volt™ Pulsed Field Ablation (PFA) System to treat atrial fibrillation. This system, already approved in the EU, uses high-energy electrical pulses for minimally invasive treatment. The approval follows the successful VOLT-AF IDE study, confirming its safety and effectiveness. Abbott plans to start commercial PFA cases in the U.S. and expand in the EU.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments